Clinical Trial Update: A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC

View source ↗

Summary

A Pan-Asian clinical database is being established to study EGFR Exon 20 insertion-mutated non-small cell lung cancer, and the study is currently recruiting. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Advanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung Cancer | Status: RECRUITING